Search Results - "Dziewanowska, Z"

BCL-2 antisense therapy in patients with non-Hodgkin lymphoma by Webb, A, Cunningham, D, Cotter, F, Clarke, P A, di Stefano, F, Ross, P, Corbo, M, Dziewanowska, Z

“…Overexpression of BCL-2 is common in non-Hodgkin lymphoma and leads to resistance to programmed cell death (apoptosis) and promotes tumorigenesis. Antisense…”
Get more information

Dichloroacetate: Population Pharmacokinetics with a Pharmacodynamic Sequential Link Model by Williams, Paul J., Lane, James R., Turkel, Catherine C., Capparelli, Edmund V., Dziewanowska, Zofia, Fox, Anthony W.

“…Dichloroacetate (DCA) is a small molecule that reduces ambient concentrations of lactate in man. It was the purpose of this study to develop pharmacokinetic…”
Get full text

Globalization of the pharmaceutical industry: opportunities for physicians in clinical research by Dziewanowska, Z E

Get more information

Circadian changes in the bioavailability and effects of indomethacin in healthy subjects by Clench, J, Reinberg, A, Dziewanowska, Z, Ghata, J, Smolensky, M

“…Nine subjects, 19 to 29 years old (2 females) synchronized with activity from 07.00 to 00.00 received a single daily oral dose (100 mg) of indomethacin at…”
Get full text

The influence of blood chemistry on T4 and FT4I in major depression by Chen, C J, Sikes, C R, Dziewanowska, Z E, Stokes, P E

“…The pathophysiology underlying thyroid dysfunction in some depressed patients has not yet been determined. In order to clarify possible biochemical influences…”
Get more information

The human interferons by Dziewanowska, Z E, Pestka, S

Get more information

Efficacy and safety of denileukin diftitox (Dd) in a phase III, double-blind, placebo-controlled study of CD25+ patients with cutaneous T-cell lymphoma (CTCL) by Negro-Vilar, A., Dziewanowska, Z., Groves, E. S., Stevens, V., Zhang, J. K., Prince, M., Martin, A., Sterry, W.

“…Abstract only 8026 Background: ONTAK®(Dd), a genetically engineered fusion protein combines the enzymatically active domain of diphtheria toxin with the…”
Get full text

Components of metabolic syndrome correlate with longer survival in NSCLC in bexarotene-treated patients with high hypertriglyceridemia in SPIRIT I and II trials: A retrospective analysis by Dziewanowska, Z., Zhang, J., Sun, S., Groves, E., Negro-Vilar, A.

“…Abstract only 7137 Background: Bexarotene activates RXR receptors regulating cell proliferation, differentiation, apoptosis and many aspects of lipid…”
Get full text

Intravenous and intramuscular pharmacokinetics of recombinant leukocyte A interferon by BORNEMANN, L. D, SPIEGEL, H. E, DZIEWANOESKA, Z. E, KROWN, S. E, COLBURN, W. A

“…Interferon is currently being evaluated for the treatment of disseminated cancer and viral diseases. Alpha interferons have shown to be effective in the…”
Get full text

Biomarker correlates of survival in NSCLC: Role of RXRβ and PPARγ in mediating bexarotene impact on patient survival by Negro-Vilar, A., Gatzemeier, U., Ramlau, R., Sun, S. L., Negro-Vilar, R., Hermann, T., Zhang, J. K., Dziewanowska, Z.

“…Abstract only 7227 Background: Bexarotene is a selective modulator of retinoid X nuclear receptors (RXRs), which form heterodimers with many other nuclear…”
Get full text

A randomized phase III trial comparing bexarotene/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) by Blumenschein, G. R., Khuri, F., Gatzemeier, U., Miller, W. H., von Pawel, J., Rigas, J. R., Herbst, R. S., Dziewanowska, Z., Negro-Vilar, A., Mabry, M.

“…Abstract only…”
Get full text

A randomized phase III trial comparing bexarotene/cisplatin/vinorelbine versus cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) by Jassem, J., Zatloukal, P., Ramlau, R., Schwarzenberger, P. O., Orlov, S., Rodrigues-Pereira, J., Temperley, G. J., Mabry, M., Negro-Vilar, A., Dziewanowska, Z.

“…Abstract only…”
Get full text

O-086 A phase III randomized trial of carboplati/paclitaxel, with or without bexarotene (Targretin®), in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC) by Gatzemeier, U., Blumenschein, G., Jotte, R., von Pawel, J., Miller, W., Khuri, E., Rigas, J., Mabry, M., Dziewanowska, Z., Negro-Vilar, A.

Get full text

P-562 Evaluation of bexarotene (Targretine®) in combination with cisplatin and vinorelbine in chemotherapy-naïve patients with advanced stage IIIb/IV non-small cell lung cancer (NSCLC) by Ramlau, R., Zatloukal, P., Tadokoro, H., Jassem, J., Hao, D., Orlov, S., Gottfried, M., Mabry, M., Negro-Vilar, A., Dziewanowska, Z.

Get full text

Studies on extravagal control of respiration by Dziewanowska, Z, Szereda-Przestaszewska, M

Get more information

A chronopharmacological study on hydrochlorthiazide by Mills, J N, Waterhouse, J M, Minors, D S, Dziewanowska, Z E

Get more information

Investigations on the neural control of respiration in experimental constriction of the upper airways by Dziewanowska-Kunert, Z

“…The adaptation of the work of the respiratory centers to suddenly arising respiratory resistance has been the object of interest of numerous investigators…”
Get full text

The physiological disposition of (6,7-dichloro-2-methyl-1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in man and mouse by Zacchei, A. G., Wishousky, T. I., Dziewanowska, Z. E., De Schepper, P. J., Hitzenberger, G.

Get full text

Effect of the increase of respiratory resistances on the bioelectric activity of phrenic neurons and the neural control of the function of the diaphragm by Dziewanowska-Kunert, Z

Get more information

Effect of experimental tracheal stenosis on the activity of respiratory motor neurons of the vagus nerve by Dziewanowska-Kunert, Z

Get more information